{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ROBERT CYRAN", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "CYRAN"}]}, "abstract": null, "type_of_material": "News", "word_count": "345", "lead_paragraph": "The diligence of the board of Alere, a diagnostic tester, brought a chunky 51 percent premium in the $5.8 billion sale to Abbott, announced on Monday.", "pub_date": "2016-02-02T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Strategy of Alere Board Paid Off With Buyout by Abbott", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "The diligence of the board of Alere, a diagnostic tester, brought a chunky 51 percent premium in the $5.8 billion sale to Abbott, announced on Monday.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/02/02/business/dealbook/strategy-of-alere-board-paid-off-with-buyout-by-abbott.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Abbott Laboratories", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Alere Inc", "name": "organizations"}], "blog": [], "_id": "56af9db138f0d8491255922f", "source": "The New York Times"}